Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer
Sanaz Taromi(University of Freiburg), Robert Zeiser(University of Freiburg), Markus G. Manz(Ospedale San Giovanni Bellinzona), Annette Schmitt‐Graeff, Lukas M. Braun(University of Freiburg), Petya Apostolova(University of Freiburg), Meike Burger(University Medical Center Freiburg), Alexander Simonis(University of Cologne), Katrin Schmittlutz(University of Freiburg), Marie Follo(University of Freiburg), Alicia Schumacher(University of Freiburg), Dominik von Elverfeldt(University Medical Center Freiburg), Xuekai Zhu(China State Shipbuilding (China)), Sven Diederichs(University of Freiburg), Gabriele Niedermann(German Cancer Research Center), Elke Firat(University of Freiburg), Simon Lagies(University of Freiburg), Bernd Kammerer(University of Freiburg), Justus Duyster(University of Freiburg), Bernward Passlick(University of Freiburg), Mirjam Elze(University of Freiburg), Anna Frey
Cited by 32
Related Papers
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k
Engineering Multifunctional Capsules through the Assembly of Metal–Phenolic Networks
|Angewandte Chemie International Edition|2014|1.1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Immune modulatory effects of oncogenic KRAS in cancer
|Nature Communications|2020|373